Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2021.09.02

Sai Life Sciences’ API Manufacturing unit receives ‘CII Excellent Energy Efficient Unit’ award

Sai Life Sciences’ API Manufacturing unit receives ‘CII Excellent Energy Efficient Unit’ award

Sai Life Sciences, a global CRO & CDMO offering sustainable solutions to pharmaceutical companies through strategic partnerships and integrated drug discovery and development services, has been awarded with ‘Excellent Energy Efficient Unit’ in the general category at CII’s 22nd National Energy Management Awards. This is the second consecutive year that Sai Life Sciences’ Bidar API manufacturing unit has been awarded by CII for its energy management.  

Congratulating the team, Krishna Kanumuri, CEO & Managing Director said, ‘’The consistency of our performance in energy conservation and sustainability parameters in the past two years speaks volumes on the commitment of our engineers and utility managers who are relentless in their focus and consistently come up with innovative solutions to take us closer to our sustainable development goals.”

The 22nd edition of National Award for Excellence in Energy Management is a flagship event of Confederation of Indian Industries (CII) with the objective to recognize and award excellence in energy management and facilitate the sharing of information on best practices and technologies. CII’s National Energy Award is the best platform for the organizations that have made outstanding contributions in energy efficiency to showcase their efforts and achievements.

The Bidar API manufacturing facility of Sai Life Sciences has been on a path of significant expansion with its production capacity growing from 200KL in 2017 to 450KL today and on course to be 600KL in 2022. Along the way it has ensured a steadfast commitment to safer, compliant and sustainable manufacturing practices.

Key energy conservation performance indicators of the site FY21

The following improvements in the site’s energy performance were achieved while sustaining a significant increase in the overall production of finished goods YoY:

Energy cost reduction
- 10% drop in thermal cost
- 5% drop in electrical cost

Energy consumption reduction
- 7.7% drop in thermal consumption
- 5.5% drop in electrical consumption

Specific Energy Consumption (SEC)
- 19% reduced w.r.t MTOE/ Ton of FG

Energy conservation projects (energy saving)
- FY20: 0.40 million kWh units/annum (Rs.3.03 million/ year)
- FY21: 1.33 million kWh units/annum (Rs.9.64 million/ year)

CO2 Emissions
- FY20: 338 Tons CO2 / ton FG
- FY21: 210 Tons CO2 / ton FG (37 % drop compared to FY20)

Renewable Energy Adoption
- FY 2020: 21%
- FY 2021: 53%

The recognition of Bidar manufacturing unit has followed the recent milestone of Sai Life Sciences becoming a signatory of United Nations Global Compact and receiving a 5-star rating for excellence in EHS practices at the 13th edition of the Confederation of Indian Industry’s (CII-SR) EHS Excellence Awards.

Share article

More News

2026.03.10

AI-driven retrosynthesis integrated into Discovery Chemistry

Sai Life Sciences has entered into a collaboration with Chemical.AI, a technology company specialising in computer-aided synthesis design, to integrate an AI-driven retrosynthesis platform into its Discovery Chemistry workflows. The integration enables medicinal chemists to evaluate synthetic routes more rapidly and explore a broader set of feasible pathways during early-stage drug discovery. Retrosynthesis is a […]
Read more

2026.03.10

Structural Biology capabilities launched with X-Ray Crystallography

Sai Life Sciences has introduced integrated structural biology capabilities with the establishment of X-ray protein crystallography workflows to support structure-based drug discovery programs. The platform encompasses end-to-end protein engineering capabilities, including construct design, gene synthesis, and in-house recombinant protein expression and purification. These foundational steps enable generation of high-quality protein material suitable for structural and […]
Read more

2026.03.09

New Medicinal Chemistry block set for inauguration in Hyderabad

A new Medicinal Chemistry block, Unit VIII, is set for inauguration at IKP, Genome Valley, Hyderabad, expanding discovery capacity to meet growing program demand. The four-floor facility spans approximately 100,000 sq. ft. and is designed to support large, multi-disciplinary project teams. It accommodates more than 200 fume hoods and includes a tightly integrated analytical laboratory […]
Read more

2026.03.09

AI-enabled production and material planning platform implemented

Over the past several months, focused AI pilot initiatives have been conducted across operations to evaluate practical applications that strengthen execution. One such initiative is now live across the network: Optimus, an integrated AI-enabled production and material planning platform, implemented at the end of December 2025. Optimus consolidates capacity planning, equipment allocation, and material availability […]
Read more

2026.03.09

Commercial-scale Photo Flow Chemistry successfully executed in Bidar

Commercial-scale flow chemistry has been successfully executed at our API manufacturing site in Bidar for a late-phase program supporting a US-based innovator. This execution builds on prior investments in continuous processing infrastructure at the site, including a 3-litre photo flow reactor equipped with a monochromatic blue LED light source. The platform enables controlled photochemical transformations […]
Read more